Potential Efficacy of Pegylated Interferon-α and a Nucleos(t)ide Analogue as Combination Therapy for HBeAg-Positive Chronic Hepatitis B

Background/AimsDespite the potent suppression of the hepatitis B virus with modern antiviral agents, only a minority of HBeAg-positive patients achieve hepatitis B e antigen seroconversion. We aimed to explore the potential efficacy of combination therapy consisting of pegylated interferon (p-IFN) a...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Chung-Il Wi, W. Ray Kim, John B. Gross, Linda M. Stadheim, John J. Poterucha
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Gastroenterology Council for Gut and Liver 2016-07-01
Saila:	Gut and Liver
Gaiak:	combination antiviral therapy hbeag-positive chronic hepatitis b hbe seroconversion pegylated interferon entecavir or tenofovir
Sarrera elektronikoa:	http://gutnliver.org/journal/view.html?doi=10.5009/gnl14256
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!